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Heterogeneous nuclear ribonucleoprotein (hnRNP)
A2 binds a 21-nucleotide myelin basic protein mRNA
response element, the A2RE, and A2RE-like sequences
in other localized mRNAs, and is a trans-acting factor in
oligodendrocyte cytoplasmic RNA trafficking. Recombi-
nant human hnRNPs A1 and A2 were used in a biosensor
to explore interactions with A2RE and the cognate oli-
godeoxyribonucleotide. Both proteins have a single site
that bound oligonucleotides with markedly different se-
quences but did not bind in the presence of heparin.
Both also possess a second, specific site that bound only
A2RE and was unaffected by heparin. hnRNP A2 bound
A2RE in the latter site with a Kd near 50 nM, whereas the
Kd for hnRNP A1 was above 10 mM. UV cross-linking
assays led to a similar conclusion. Mutant A2RE se-
quences, that in earlier qualitative studies appeared not
to bind hnRNP A2 or support RNA trafficking in oligo-
dendrocytes, had dissociation constants above 5 mM for
this protein. The two concatenated RNA recognition mo-
tifs (RRMs), but not the individual RRMs, mimicked the
binding behavior of hnRNP A2. These data highlight the
specificity of the interaction of A2RE with these
hnRNPs and suggest that the sequence-specific A2RE-
binding site on hnRNP A2 is formed by both RRMs act-
ing in cis.
The family of more than 20 heterogeneous nuclear ribo-
nucleoproteins (hnRNPs)1 appears to play diverse roles in the
post-transcriptional processing of hnRNA and subsequent
packaging, transport, and translation of mRNA (1–4). hnRNPs
A1, A2, B1, B2, C1, and C2 are the major components of 40S
“core particles,” studied primarily in HeLa cells, which are
thought to package nascent ssRNA in the nucleus in a histone-
like fashion (5–10). The hnRNP A/B proteins have a modular
structure with two N-terminal RNA recognition motifs (RRMs)
followed by a glycine-rich region (Fig. 1) (11). The three-dimen-
sional structures of the tandem RRMs of hnRNP A1, which are
assumed to be the principal mediators of the RNA-protein
interactions, have been determined (12, 13). Although the
three-dimensional structures of other hnRNPs of the A/B fam-
ily have not been determined, their RRMs share sufficient
sequence identity with those of hnRNP A1 to suggest that they
share the same tertiary fold: a four-stranded antiparallel
b-sheet flanked by two helices. This module adopts a compara-
ble fold in the RRMs of more distantly related proteins, such as
U1A (14–17).
Although a number of the hnRNPs have a general role in
intranuclear packaging of RNA, some also manifest sequence-
specific binding (1, 4, 18–22). In addition to being a major
component of core particles (23), hnRNP A2 binds a telomeric
sequence (24, 25, 43) and a small RNA segment known to be
necessary and sufficient for transport of the message encoding
myelin basic protein in the cytoplasm of oligodendrocytes, the
A2RE (26–28). The binding of hnRNP A2 to A2RE has been
shown, by mutational and antisense approaches, to be essential
for cytoplasmic RNA trafficking in oligodendrocytes (29).
Although hnRNP A2 has been shown to bind A2RE (29–31),
the number of binding sites, their affinities, and location are
unknown. We have used a resonant mirror biosensor and UV
cross-linking gel mobility shift assays to investigate the bind-
ing of the A2RE and other oligoribonucleotides to recombinant
human hnRNPs A1 and A2 and rat hnRNP A2. These proteins
are shown to possess a single site that can associate with
oligonucleotides with widely different base sequences. Both
also possess a second site that is specific for A2RE, with con-
siderably stronger binding to hnRNP A2 than hnRNP A1. Hep-
arin inhibits the nonspecific interaction but not the binding of
the A2RE to its specific site. We also show that an oligonucleo-
tide consisting of the 59 11 nucleotides of A2RE binds as
strongly as the 21-mer, thereby defining more precisely the
dimensions of the segment of the A2RE that is recognized by
hnRNP A2 and identifying one of the smallest single-element
RNA-localization motifs. Finally, experiments with expressed
and purified modules of hnRNP A2 indicate that the specific
A2RE-binding site is formed by the two RRMs acting in con-
cert, whereas single RRMs are capable of interacting only
weakly or nonspecifically with RNA.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—hnRNP A1 was expressed in
Escherichia coli and purified from the centrifuged cell lysate by passage
through columns of DEAE-cellulose (Whatman Bioscience, Cambridge,
United Kingdom), AGPoly(U) (Amersham Pharmacia Biotech), and
phenyl-Superose (Amersham Pharmacia Biotech) columns (32). Human
hnRNP A2 was expressed in E. coli and purified as described previously
(29). Rat hnRNP A2 was isolated from brain extracts by using super-
paramagnetic particles bearing A2RE (30). Briefly, brains were re-
moved from 21-day-old Wistar rats and homogenized. The homogenate
was centrifuged at 13,000 3 g for 25 min at 4 °C, and the supernatant
was collected. 0.5 mg of streptavidin-coated magnetic particles (Roche
Molecular Biochemicals) was incubated on ice for 10 min with 2 mg of
biotinylated A2RE or dA2RE. Unbound RNA was washed off, and about
5 mg of brain protein was added to the magnetic particles and incubated
for 30 min on ice. Heparin was used to reduce nonspecific binding. Then
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the particles were washed to remove unbound proteins, and the bound
proteins were released by incubation in 100 ml of 30% acetonitrile, 0.1%
trifluoroacetic acid and purified by reverse-phase HPLC. Segments of
hnRNP A2 were expressed, also in E. coli BL21(DE3), with cleavable
hexahistidine and SzTagTM using the vector pET30b1 (Novagen, Mad-
ison, WI). The human hnRNP A2 fragments generated were residues
1–89, 101–179, 1–179, and 1–189, each with the N-terminal extension
Ala-Met-Ala-Ile-Ser from the expression vector. Chromatography on a
metal affinity resin (Talon, CLONTECH, Palo Alto, CA) was used to
isolate the fusion proteins from cell lysates, and they were then cleaved
with 1 unit of recombinant enterokinase (Novagen)/50 mg protein for
16 h at 25 °C. The resultant proteins were purified by reverse-phase
HPLC on a C18 column (Vydac, Hesperia, CA) using gradients of
acetonitrile in 0.1% trifluoroacetic acid. Fractions containing protein
were lyophilized and finally dissolved in water. The identity and purity
of all proteins was established by polyacrylamide gel electrophoresis in
the presence of sodium dodecyl sulfate and by electrospray mass spec-
trometry on a PerkinElmer Sciex 165 spectrometer: all were judged to
be better than 90% pure. Rat hnRNP A2 had a mass of 36,086 6 10: as
the calculated average mass for rat hnRNP A2 is 36,040 (including
assumed N-terminal acetylation as the protein is known to be N-
terminally blocked), it appears that this protein has additional post-
translational modification, the nature of which cannot be deduced from
the mass values alone. In parallel experiments in which rat brain
hnRNP A2 was substituted for the recombinant human protein, the
biosensor responses were quantitatively similar, suggesting that the
post-translational modification of the rat protein does not strongly
influence oligonucleotide binding.
Oligonucleotides—A2RE (GCC AAG GAG CCA GAG AGC AUG),
A2RE11 (GCC AAG GAG CC), NS1 (CAA GCA CCG AAC CCG CAA
CUG), NS2 (AGA AAG AGA CCC UCA CGA CUG), corresponding
oligodeoxyribonucleotides (dA2RE and dNS1), and A2RE11 oligoribo-
nucleotides mutated in single positions (C3G, G7A, A8G, G9A (29))
were synthesized and purified by Oligos Etc. (Wilsonville, OR) with or
without 39 biotinylation. The concentrations of oligonucleotide solutions
were calculated from the measured absorbance at 260 nm (33) with
allowance for the presence of biotin where appropriate.
Biosensor Preparation—An IAsys resonant mirror biosensor (Affinity
Sensors, Cambridge, UK) was used to determine the equilibrium affin-
ities for the interactions of hnRNPs with A2RE and other related
oligonucleotides, NS1 and NS2 being chosen as controls to distinguish
specific from nonspecific binding. Although it is customary to maximize
the response by attaching the smaller of the two interacting molecules
to the biosensor surface, in some experiments we chose to immobilize
the hnRNP A2 (Mr 36,000) rather than the RNA (Mr 7200 maximum).
Immobilization of the protein not only avoided the possibility of degra-
dation of the potentially labile RNA on the sensor surface but also
allowed investigation of the binding of different RNAs on a single
cuvette. Purified hnRNP A2 was covalently attached to the carboxy-
methyldextran-coated sensing surface of the biosensor cuvette using
the standard 1-ethyl-3-[3-(dimethylamino)propyl] carbodiimide/N-hy-
droxysuccinimide (Advanced Laboratory Solutions, Melbourne, Austra-
lia) procedure for random coupling via amino groups of the protein (34).
The protein was prepared as 0.1 g/liter solutions at pH 5.0 in 10 mM
acetate buffer for attachment to the cuvette; sedimentation equilibrium
experiments yielded a linear ln c versus r2 plot with a slope that
indicated that hnRNP A2 has a molecular weight of 36,000 6 4000
under these conditions. It may therefore be assumed that the oligonu-
cleotides bind to monomeric protein. After removal of the uncoupled
hnRNP A2 by washes with phosphate-buffered saline (10 mM sodium
phosphate, 138 mM NaCl, 2.7 mM KCl), pH 7.4, containing 0.05% v/v
Tween 20 (Sigma) (PBS/T), the residual activated ester groups were
inactivated by exposure to ethanolamine. The cuvette was then washed
with PBS/T buffer containing 2 M NaCl to remove any noncovalently
bound protein, a step that had no effect on the ability of the immobilized
hnRNP to interact with the A2RE. The typical response of 1200–2600
arc s for the immobilized human hnRNP A2 on different cuvettes
corresponds to the coupling of 8–17 ng/mm2 of sensor surface. The
corresponding values for the rat protein were 3000 arc s and 20 ng/mm2.
In other experiments biotinylated oligodeoxyribonucleotides were
attached to cuvettes bearing avidin (Sigma) prepared as discussed
below. The hnRNPs appear to have equal affinity for equivalent oligori-
bonucleotides and oligodeoxyribonucleotides, and the use of 29-de-
oxynucleotides therefore yields more stable biosensors without affecting
FIG. 1. Comparison of the primary
structures of hnRNPs A1 and A2.
These proteins have two RRM domains,
in boxes, followed by a glycine-rich do-
main. The two highly conserved se-
quences within the RRMs, the hexameric
RNP2 and the octameric RNP1, are in
bold letters. Asterisks mark non-identical
residues, and the residues 180–189 of
hnRNP A2 are underlined. The RRM do-
main limits are those of Kozu et al. (50).
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the binding experiments. After washing the biosensor cuvette with
PBS/T, equivalent amounts of biotinylated dA2RE or dNS1 were added
to cuvettes and left until the responses reached equilibrium (;20 min).
5 mM NaOH was used to remove unbound oligonucleotide. The cuvettes
were then washed extensively with PBS/T to establish a base line before
hnRNP solutions of different concentrations in PBS/T were added.
Binding of hnRNP to Immobilized Oligonucleotide—Because of the
limited solubility of the hnRNPs and the fragments of hnRNP A2, the
protein solutions were prepared by 50–100-fold dilution of concentrated
stock solutions into PBS/T shortly before use in the biosensor. Freshly
diluted solutions were used for each measurement. The concentrations
of the proteins in these solutions were determined by amino acid anal-
ysis of 24-h acid hydrolsates with norleucine as the internal standard;
the amounts of several of the stable amino acids were used with the
known amino acid sequences to calculate the molar concentrations.
Binding of protein was monitored at 0.4-s intervals at 25 °C in PBS/T
until equilibrium had been attained (;15 min). After binding measure-
ments, removal of the cuvette contents was followed by a rinse with
PBS/T. The cuvettes were regenerated by removal of bound protein with
5 mM NaOH before washes with PBS/T to re-establish the base line for
the next experiment.
Binding of RNA to Immobilized hnRNP A2—PBS/T (100 ml) was first
placed in the hnRNP A2-modified cuvette and the response monitored
for 5 min to establish a base line, after which aliquots of a stock solution
of RNA in PBS/T were added to achieve a range of concentrations in the
liquid phase. The binding of RNA was monitored routinely for 10–15
min, by which time equilibrium had been attained. Removal of the
cuvette contents was followed by rinsing with PBS/T. The cuvettes were
regenerated by removal of bound RNA with PBS/T containing 2 M NaCl
before washes with PBS/T to re-establish the base line for the next
experiment. Competition experiments followed the same general proto-
col except that mixtures containing a fixed concentration of A2RE (1
mM) and a range of soluble hnRNP A2 concentrations were placed in the
cuvette for monitoring of the association phase until attainment of
equilibrium. Subsequently, the cuvette was washed with PBS/T-2 M
NaCl to remove the RNA and protein, and the base line re-established
after washing the cuvette with PBS/T. In a third series of experiments
designed to determine the effect of heparin on interaction between
oligoribonucleotides and immobilized hnRNP A2, the glycosaminogly-
can (from porcine intestinal mucosa, sodium salt, Mr 500 000; Sigma)
was included in the buffer at a concentration of either 1 or 10 g/liter.
Analysis of Data—In keeping with the procedure adopted in most
biosensor studies with the IAsys instrument (35), the approximation
has been made that the extent of complex formation between added
oligoribonucleotide (O) and the immobilized hnRNP A2 is sufficiently
small to allow substitution of the total RNA concentration (CO)tot for its
free counterpart, CO. The reliability of this approximation was checked
by means of the following expression (Equation 1),
CO 5 ~CO)tot 2 ~100V!@Req/~MO 0.8 3 815,000!# (Eq. 1)
where V is the volume of liquid in the cuvette (ml), MO is the RNA
molecular weight (7200 for A2RE), and the calibration constant is taken
as 80% of that for proteins (36) to accommodate the difference between
the specific refractive increments of protein and nucleic acids.
Estimates of thermodynamic dissociation constant, Kd, for the inter-
action of oligoribonucleotides with immobilized hnRNP A2 were ob-
tained by nonlinear regression analysis of the concentration depend-
ence of the equilibrium response, Req, in terms of the rectangular
hyperbolic relationship (see Equation 2),
Req 5 RmaxCO/~Kd 1 CO! (Eq. 2)
to obtain as two curve-fitting parameters the magnitudes of Kd and
Rmax, the maximal response associated with saturation of all immobi-
lized hnRNP A2 sites (37). An equivalent analysis was performed for
experiments in which oligodeoxyribonucleotide was immobilized on the
biosensor cuvette.
Because the equilibrium constant in Equation 2 refers to the inter-
action of oligoribonucleotide with a chemically modified (immobilized)
form of hnRNP A2, competition experiments were performed to obtain
a quantitative characterization that refers unequivocally to the inter-
action between A2RE and hnRNP A2 in solution. Competitive binding
assays involving the measurement of binding responses for mixtures of
oligoribonucleotide and hnRNP A2 were analyzed by determining the
free oligoribonucleotide concentration, CO, on the basis of the measured
equilibrium response and a calibration plot, Req versus CO, constructed
from the data for oligoribonucleotide alone. Knowledge of CO for a
mixture with total oligoribonucleotide and hnRNP A2 concentrations,
(CO)tot and (CH)tot9 respectively, allowed evaluation of the binding func-
tion, r (see Equation 3),
r 5 @~CO!tot 2 CO#/~CH!tot (Eq. 3)
Analysis of the resulting [r, CO] data in terms of the rectangular
hyperbolic relationship (see Equation 4)
r 5 n~CO!/~Kd 1 CO! (Eq. 4)
was then used to determine not only the dissociation constant for the
interaction between oligoribonucleotide and hnRNP A2 in solution but
also n, the number of binding sites for oligoribonucleotide on hnRNP
A2.
Electrophoretic Mobility Shift Assays—Recombinant and rat proteins
were obtained as described above. Rat brain proteins to be used in UV
cross-linking experiments were removed from A2RE-linked magnetic
particles by incubation in 300 mM MgCl2 for 1 h at 4 °C. Eluted proteins
were dialyzed against 10 mM HEPES, pH 7.5, containing 40 mM NaCl
and 5% glycerol and used directly or subjected to reverse-phase HPLC
to isolate the hnRNP A2.
Equimolar amounts of oligoribonucleotide, 32P-labeled with T4
polynucleotide kinase (New England Biolabs, Beverly, MA), and
equimolar amounts of each protein were mixed in binding buffer (10 mM
Tris-HCl, pH 7.5, containing 1 mM EDTA, 4% w/v gylcerol, 0.1% w/v
Triton X-100, and 1 mM dithiothreitol) and incubated for 30 min on ice.
The reaction mixtures were then irradiated with 250 mJ of 254 nm light
in a Bio-Rad GS Genelinker UV chamber. These samples were run on
15% sodium dodecyl sulfate (SDS)-polyacrylamide gels that were ex-
posed to autoradiography film.
FIG. 2. hnRNP A2 shows sequence-specific oligonucleotide
binding in biosensor. dA2RE and dNS1 were immobilized on the two
compartments of a single biosensor cuvette; for both the biosensor
response on addition of the oligonucleotide was 260 arc s, indicating
that equal amounts were immobilized. Solutions of hnRNPs A1 and A2
in PBS/T were added, in separate experiments, to yield a final concen-
tration of 4 mM. The data reveal a 2-fold greater binding of hnRNP A2
(B) compared with hnRNP A1 (A) to dA2RE. hnRNP A1 binds the
nonspecific oligonucleotide dNS1 and dA2RE equally. In this experi-
ment the immobilized oligonucleotides were DNA rather than RNA, to
lessen the chances of degradation. Inset in A, Coomassie Blue-stained
SDS-polyacrylamide gel showing equivalent binding of rat brain
hnRNP A2 (36 kDa) to A2RE and dA2RE. The positions of standard
proteins are shown at left. Biosensor experiments (Figs. 5 and 6) have
also shown that the binding to the hnRNPs is not affected by the
presence or absence of the 29-OH group.
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RESULTS
hnRNP A2 Possesses Sequence-specific and Nonspecific RNA-
binding Sites—Biosensor data (Fig. 2) were recorded for non-
saturating concentrations of hnRNPs A1 and A2 (purity shown
in Fig. 10) with A2RE and an equivalent oligonucleotide in
which the base sequence had been randomly modified (NS1)
(30), immobilized in the two compartments of a biosensor cu-
vette. The biosensor responses showed that these hnRNPs
bound both oligonucleotides; however, there were marked dif-
ferences between them. Both bound NS1 to a similar extent
and hnRNP A1 also produced an almost equal response with
A2RE, but the response with A2RE and hnRNP A2 was 2-fold
higher, suggesting that it possesses site(s) that bind NS1 and
others that bind A2RE but not NS1. These experiments were
performed with oligodeoxyribonucleotides rather than oligori-
bonucleotides immobilized on the biosensor to enhance the
biochemical stability of the biosensor cuvette during repeated
usage. We have evidence from a number of approaches that the
presence or absence of the 29-hydroxyl group does not influence
the hnRNP-oligonucleotide interactions; for example, the inset
in Fig. 2A shows equivalent binding of rat brain proteins (pre-
dominantly hnRNP A2) to magnetic particles bearing A2RE
and dA2RE.
The conclusion drawn above was explored further by using
UV cross-linking electrophoretic mobility shift assays (Fig. 3).
32P-Labeled oligoribonucleotides were cross-linked to bound
proteins by exposure to UV light and then subjected to SDS-
polyacrylamide gel electrophoresis and autoradiography. In ac-
cord with the above biosensor results, hnRNP A2 was found to
bind both A2RE and NS1, with a clear preference for the
former. This binding to A2RE was largely eliminated by addi-
tion of a 50-fold excess of unlabeled A2RE but not by an equiv-
alent amount of unlabeled NS1. Labeled NS1 did not bind in
the presence of a 50-fold excess of unlabeled NS1 or A2RE.
Purified rat brain hnRNP A2 and the mixture of rat brain
A2RE-binding proteins eluted from the magnetic particles
manifested similar behavior (data not shown), except that the
latter did not show any binding to NS1; this is in contrast to the
recombinant proteins that bind NS1, albeit less strongly than
they bind A2RE. hnRNP A1 bound both A2RE and NS1, though
more weakly to both than hnRNP A2. The binding of hnRNP
A1 to A2RE was stronger than to NS1, suggesting sequence-
specific binding that is weaker than that of hnRNP A2. As for
hnRNP A2, the association of hnRNP A1 with both A2RE and
NS1 was eliminated on addition of a 50-fold excess of A2RE,
but only NS1 binding was eliminated by a 50-fold excess of
NS1.
The inference that hnRNP A2 possesses a strong binding site
for A2RE that does not bind other oligoribonucleotides of the
same length and base composition was confirmed by modifying
the experiment depicted in Fig. 2. hnRNP A2 was immobilized
on a cuvette and a saturating concentration of one of two
nonspecific oligoribonucleotides (10 mM NS1 or NS2) or A2RE
(500 nM) added. As anticipated from the data in Fig. 2, the
FIG. 3. UV cross-linking experiments show sequence-specific A2RE binding. Electrophoretic mobility-shift assays show binding of A2RE
and NS1 to hnRNPs (band marked by double arrowhead). 1.4 nmol of 32P-labeled A2RE or NS1 oligoribonucleotides were added separately to
purified 1 pmol of recombinant hnRNPs A1 or A2 and UV cross-linked, in the absence of heparin, prior to analysis by SDS-polyacrylamide gel
electrophoresis and autoradiography. Competition experiments show that, for both proteins, a 50-fold excess of unlabeled A2RE competes with both
labeled A2RE and NS1, whereas a 50-fold excess of unlabeled NS1 competes only with labeled NS1. The bands of unbound oligonucleotide, which
ran with the marker dye, are not shown. The upper bands visible in most lanes (single arrowhead) were not obtained consistently and may arise
from dimer formation The positions of marker proteins, with molecular masses in kilodaltons, are shown at right.
FIG. 4. hnRNP A2 possesses sequence-specific and nonspecific
RNA binding sites. The data in Fig. 2 show that hnRNP A2 binds
more A2RE than hnRNP A1. Here we show that hnRNP A2 possesses
sites that are sequence-specific and nonspecific. Comparison of the
IAsys biosensor time course for the binding of A2RE (to 500 nM) to
immobilized hnRNP A2 with that for oligoribonucleotides with the
same composition but scrambled sequence (NS1 and NS2; to 10 mM). A,
A2RE, or NS1 or NS2, was added to the cuvette at time 0. After
attainment of binding equilibrium with the immobilized hnRNP A2,
A2RE sufficient to increase its concentration by 500 nM was added to
each cuvette at the time indicated by the arrow. Only the hnRNP A2
previously equilibrated with NS1 or NS2 showed increased binding on
addition of the second aliquot of oligonucleotide, suggesting that the
protein possesses sites that bind A2RE but not equivalent oligonucleo-
tides with scrambled sequences. B, in a parallel experiment, 10 mM NS1
or NS2, rather than A2RE, was added at the time indicated by the
arrow after the attainment of equilibrium. Addition of further NS1 or
NS2, in contrast to A2RE, results in only a minor increase in binding at
the subsaturating concentrations used.
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response with A2RE was double that with NS1 or NS2. After
attainment of equilibrium (arrow, Fig. 4A), sufficient A2RE
was added to each biosensor to raise its concentration by 500
nM. This addition led to little change in the response on addi-
tion to A2RE but to a doubling of the biosensor response on
addition of A2RE to the cuvette previously containing only NS1
or NS2. By contrast, addition of a further aliquot of NS1 or NS2
to the cuvettes previously equilibrated with these oligoribo-
nucleotides did not further increase the biosensor response
(Fig. 4B).
Heparin Eliminates Binding at the Nonspecific Site—Addi-
tional evidence for the description of the two classes of binding
sites as nonspecific and specific was obtained by examining the
effects of addition of the polyanionic glycosaminoglycan, hepa-
rin, to the solution phase. Heparin (1 g/liter), which is com-
monly used to counter nonspecific protein-RNA interactions,
was added to solutions of the hnRNPs in biosensor cuvettes
bearing immobilized dA2RE or dNS1. Heparin diminished the
binding to both DNAs, halving the biosensor response from the
dA2RE with hnRNP A2 (Fig. 5C) and almost eliminating the
binding of dA2RE to hnRNP A1 (Fig. 5A) and of NS1 to both
proteins (Fig. 5, B and D). A 10-fold increase in the heparin
concentration, to 10 g/liter, did not further diminish the re-
sponse to the A2RE (data not shown). In view of these results
and those described in the previous section, it is unlikely that
A2RE binds only to sequence-specific sites distinct from the
NS-binding sites. Thus, the site occupied by NS1 or NS2 may
also accommodate A2RE, and it can therefore be concluded that
in addition to at least one nonspecific site, there is an equal
number of sites on hnRNP A2 that bind the A2RE selectively.
Dissociation Constants for the RNA Interactions—The bind-
ing curves in Fig. 5 were used to calculate dissociation con-
stants by nonlinear regression analysis using Equation 2. Re-
sults obtained in the absence of heparin were used to calculate
Kd for hnRNP A1 with A2RE and NS1, and for hnRNP A2 with
NS1, values that reflect binding to the nonspecific sites (Table
I). The data for A2RE binding to hnRNP A2 were fitted using a
two-site model, yielding Kd values of 59 and 220 nM for the
specific and nonspecific sites, respectively. The value of Kd, 87
nM, obtained for hnRNP A2 in the presence of heparin (Fig. 5C)
reflects binding to the specific site only. It is a little higher than
the values obtained in the absence of heparin, perhaps as a
result of the large increase in ionic strength that results from
addition of this polyanion.
The above dissociation constants, derived from experiments
in which the oligodeoxyribonucleotides were immobilized, are
in agreement with the values calculated from experiments in
which hnRNP A2 was immobilized and A2RE added in the
absence of heparin (Fig. 6A and Table I). Thus, the binding
constants appear to be uninfluenced by the tethering of the
molecules to the biosensor, a conclusion reinforced by compe-
tition experiments outlined in the next section. Experiments
with rat brain hnRNP A2 paralleled those with the recombi-
nant human protein, with nonspecific and specific binding
again evident and a Kd for the latter of ;15 nM, about 3-fold
lower than for the human protein (Fig. 6B).
Interaction between hnRNP A2 and A2RE in Solution—To
examine the interaction between hnRNP A2 and A2RE in so-
lution, experiments were performed in which solutions contain-
ing various concentrations of human hnRNP A2 and a fixed
concentration of A2RE were added to a cuvette with human
hnRNP A2 immobilized on the sensor surface. Addition of sol-
uble hnRNP A2 to this cuvette, in the absence of A2RE, caused
little change in the biosensor response. The decrease in equi-
librium response with increasing concentrations of hnRNP A2
in the A2RE-containing mixture (Fig. 7A) thus reflects compe-
tition between the soluble and immobilized forms of the protein
for A2RE and hence establishes specificity of oligoribonucle-
otide binding to the cuvette sensor surface. Furthermore, the
use of Equation 3 for evaluation of the binding function for each
reaction mixture allows conclusions to be drawn about the
strength and stoichiometry of the interaction between oligori-
bonucleotide and hnRNP A2. Nonlinear regression analysis of
the dependence of binding function upon A2RE concentration
in terms of the hyperbolic expression in Equation 4 is consist-
ent with the existence of two sites with an intrinsic dissociation
constant of 79 (63) nM. However, from the Scatchard plot of the
FIG. 5. Effect of heparin on binding of oligonucleotides to
hnRNPs A1 and A2. Equilibrium biosensor responses, with dA2RE (A,
C) or dNS1 (B, D) immobilized on the surface of an IAsys cuvette, as a
function of solution protein concentration. Data were recorded for
hnRNPs A1 (A, B) and A2 (C, D) in the absence (solid lines) and
presence (dashed lines) of 1.2 g/liter heparin. Heparin eliminates non-
specific binding (A–C) but does not interfere with A2RE binding to the
specific site (C). The data were fitted to Equation 2 assuming a single
binding site (A, B, D, and the lower curve of C) or a modified form of this
equation for two sites (upper curve of C). The Kd values derived from
these curves are presented in Table I.
hnRNP Binding to the hnRNP A2 Response Element38290
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
same data (Fig. 7B) it is apparent that the binding is poorly
described by this single rectangular hyperbolic relationship.
Better descriptions are obtained by invoking different dissoci-
ation constants for the two sites, as is evident from the simu-
lated curves for the situation where K1 5 40 nM and K2 5 320
nM (solid line), or where K1 5 50 nM and K2 5 250 nM (dotted
line). The most important point to emerge from Fig. 7B is the
overall stoichiometry of the interaction (n 5 2). Taken in con-
junction with the results presented in Figs. 5 and 6, this finding
establishes that there is a single site on hnRNP A2 that binds
oligoribonucleotides irrespective of their sequence and one ad-
ditional site that binds A2RE, but not other oligoribonucleoti-
des, with the same composition but scrambled nucleotide
sequences.
Interaction of hnRNP A2 with a Shorter Segment of A2RE—
The 21-nucleotide A2RE segment has been shown, by deletion
analysis, to be necessary and sufficient for myelin basic protein
mRNA transport in cultured oligodendrocytes (26). To define
more closely the protein-binding segment of the A2RE, we
earlier conducted affinity partition experiments with three
overlapping biotinylated 11-nucleotide fragments of the A2RE
attached to streptavidin-labeled magnetic beads (29). Those
qualitative experiments indicated that the binding of the seg-
ment comprising the first 11 nucleotides from the 59 end
(A2RE11) to hnRNP A2 is similar to that for the intact 21-
nucleotide A2RE. That observation has now been quantified by
means of the biosensor.
At saturating concentrations of A2RE11 the response was
similar to that obtained with the A2RE and again was halved
in 1 g/liter heparin (Fig. 8A). In addition, the dissociation
constant derived from experiments with a range of AR2E11
concentrations was 44 nM (Fig. 8B), which effectively duplicates
the Kd of 42–45 nM obtained for A2RE binding to immobilized
hnRNP A2. Inasmuch as these results exhibit a quantitative
parallel with those for the intact A2RE, it is concluded that the
11-base oligoribonucleotide suffices to occupy either the non-
specific or the specific site on hnRNP A2.
Binding of Point Mutants of A2RE11—Earlier experiments
in which rat brain protein binding to RNA immobilized on
FIG. 6. A2RE binding to immobilized hnRNP A2. Solutions of
A2RE were added to human recombinant (A) and rat brain (B) hnRNP
A2 and the equilibrium biosensor responses recorded. The data were
fitted to a two site model, yielding the Kd values presented in Table I.
Because the ligand in solution in these experiments is A2RE, which has
a mass 6-fold lower than hnRNP A2, the responses are smaller than
those in Fig. 5.
FIG. 7. Competitive binding data for the interaction of A2RE
with human hnRNP A2 in solution. Solutions containing A2RE (1
mM) and hnRNP A2 (233–3300 nM) were placed in an IAsys cuvette with
hnRNP A2 attached to the sensor surface. A, dependence of equilibrium
binding response upon the concentration of hnRNP A2 included in the
solution. B, Scatchard linear transform of the competitive binding data.
Lines are simulated plots for two-site systems with different affinities
ascribed to the two sites: K1 5 40 nM, K2 5 320 nM (solid line); K1 5 50
nM, K2 5 250 nM (dotted line). The units of r/CO are nM
21.
TABLE I
Binding of hnRNPs A1 and A2 to oligonucleotides
Dissociation constants (Kd in nM) were calculated from resonant mirror biosensor measurements using a single-site binding equation for NS1 and
two binding sites for A2RE. Experiments were performed with either oligonucleotide or hnRNP immobilized on the sensor cuvette.
Immobilized oligonucleotide Immobilized protein
dNS1
dA2RE A2RE
Specific Nonspecific Specific Nonspecific
Human hnRNP A1 438 6 69 .10,000 431 6 67 NDa ND
Human hnRNP A2 246 6 29 59 6 19 220 6 44 42 6 4, 45 6 5b 250 6 43, 285 6 41b
Rat hnRNP A2 ND ND ND 15 6 2 225 6 36
a ND 5 not determined.
b Averaged from competition experiment data presented in Fig. 7B.
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magnetic particles was measured semiquantitatively had
shown that single-base mutations of the A2RE11 sequence had
markedly varying effects, some not affecting binding to hnRNP
A2 and others eliminating the association. These results were
confirmed in biosensor experiments with four point-mutated
A2RE11 sequences: C3G, G7A, A8G and G9A (29). The binding
of C3G and G7A was quantitatively similar to that A2RE11,
whereas the binding of the other two mutants was indistin-
guishable from that of NS1 (Fig. 8B). From simulation of these
binding curves it was deduced that the A8G and G9A muta-
tions increased Kd by more than 50-fold for the specific site
(Table II).
A2RE-binding Site Location—Many hnRNPs possess multi-
ple RRMs. HnRNP A/B subfamily members contain two N-
terminal RRMs, both of which bind RNA. The C-terminal gly-
cine-rich tail has also been implicated in RNA binding. To
locate the A2RE binding site on hnRNP A2, we expressed and
purified several segments (Fig. 10A) and used them in biosen-
sor cuvettes bearing dA2RE and dNS1 (Fig. 9), and in UV
cross-linking experiments (Fig. 10).
In biosensor experiments the N-terminal RRM (residues
1–89) showed equivalent binding to both oligonucleotides (Fig.
9A), and A2RE binding to the second RRM (residues 101–179)
was only slightly above that of NS1 (Fig. 9B), compared with
hnRNP A2 used in the same cuvette (Fig. 9C). Thus, they bind
RNA nonspecifically and show little or no evidence of specific
A2RE binding. In contrast, the concatemer of the two RRMs
showed substantially higher binding to A2RE than to NS1 (Fig.
9D) and thus has a specific A2RE-binding site in addition to its
capacity for nonspecific binding. However, even this concate-
mer did not quantitatively mimic the binding properties of
hnRNP A2, but the addition of a further 10 residues (180–189;
EMQEVQSSRS) increased the binding (Fig. 9E) to a level com-
parable with that of the intact protein (Fig. 9F; Table III); the
equivalent segment of hnRNP A1 causes a 100-fold increase in
the binding of poly[r(eA)] (38). The effects of heparin on the
hnRNP A2 fragments were not as readily interpreted as for the
whole protein. In contrast to its effects on hnRNP A2, addition
of heparin to RRM1 or RRM2 lowered, but did not eliminate,
binding.
UV cross-linking experiments were performed with equimo-
lar amounts of hnRNPs A1 and A2 and the A2 fragments. In
contrast to the biosensor experiments, both proteins mani-
fested specific and nonspecific binding, with weaker binding to
hnRNP A1 than to hnRNP A2 (Fig. 10B). Weak binding of
A2RE and NS1 to residues 101–179 (Fig. 10C) but not to
residues 1–89 (data not shown) was detected only after ex-
tended exposure of the autoradiographs. The segments 1–179
and 1–189 bound both A2RE and (more weakly) NS1. At equiv-
alent molar concentrations A2RE binding to the intact protein
still exceeded that to residues 1–189. Two differences between
the biosensor and UV cross-linking results are the comparable
binding of hnRNPs A1 and A2 to A2RE and the marked differ-
ence in binding to the polypeptide comprising residues 1–189
and the intact proteins in the latter experiments; these results
contrast with the weak specific binding of hnRNP A1 to A2RE,
and the comparable binding of residues 1–189 and hnRNP A2,
in the biosensor. Although no definitive explanation can at
present be given for these differences, we note that the biosen-
sor data reflect the extant equilibria, whereas the cross-linking
data come from nonequilibrium measurements that may be
influenced by more efficient cross-linking, perhaps to the C-
terminal glycine-rich domain.
DISCUSSION
We have established that expressed human hnRNP A2 pos-
sesses at least two sites for binding oligonucleotides. One rec-
ognizes RNA molecules with widely differing sequences, but
with similar dissociation constants, the second is specific for
A2RE. The dissociation constants for both sites are typical of
RRM-containing proteins (20, 39, 40) and are within an order of
magnitude, but the discrimination between A2RE and other
sequences for the specific binding site on hnRNP A2 is effec-
tively absolute (Fig. 5). No binding of NS1 or NS2 to the specific
site was detected even at the highest oligonucleotide concen-
trations used in the absence of heparin. On the other hand, the
A2RE retained its affinity for the specific site in the presence of
heparin concentrations (10 g/liter), which eliminated binding at
the nonspecific site. The ability of heparin to block just one site,
and the clear discrimination between oligonucleotides possess-
ing and lacking an A2RE-like sequence observed for the other
site, signify a fundamental difference in the nature of the two
binding regions on hnRNP A2.
Most RRMs have been assumed to have a basal level of
nonspecific affinity for RNA, although only in a few instances
has this been proven (41). As constituents of core particles,
hnRNP A1 and hnRNP A2, in particular, have been proposed to
have roles in intramolecular RNA packaging, which would
presumably be independent of RNA sequence. This hypothesis
is partly supported by our data. Both isolated RRMs of hnRNP
A2 manifest nonspecific binding of comparable strength, al-
though the intact protein appears to have a single site for
FIG. 8. Mutations in the A2RE11 sequence that affect RNA
transport eliminate binding to hnRNP A2. A, biosensor response
on addition of a saturating concentration of A2RE11 to immobilized
hnRNPA2. In the absense of heparin the response mirrors that with
A2RE. In the presence of 1 g/liter of heparin, the response is halved. B,
responses from a biosensor bearing immobilized hnRNP A2 as a func-
tion of the concentration of added oligoribonucleotide. These data rein-
force the earlier conclusion from qualitative magnetic particle affinity
assays and RNA transport experiments (29) that mutations that inter-
fere with RNA transport also reduce binding to hnRNP A2. The A2RE
mutations C3G (l) and G7A ( l ) reduce binding slightly compared with
A2RE11 (f), but the two mutations A8G (E) and G9A (M), which
markedly affect RNA transport, increase the Kd for hnRNP A2 binding
by at least 50-fold. The lines are the best fits to the data assuming one
(A8G and G9A) or two (A2RE11, C3G and G7A) sites, which yielded the
dissociation constants in Table II.
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nonspecific interaction with even the relatively short A2RE.
However, in contrast to the recombinant proteins, hnRNP A2
isolated from rat brain protein extracts shows little nonspecific
binding in electrophoretic mobility shift assays performed in
the absence of heparin (29). This difference between the human
and rat proteins does not necessarily exclude the existence of
nonspecific binding sites on the rat hnRNPs; the nonspecific
RNA-binding sites on these proteins may, for example, already
be occupied in the tissue extracts, thus precluding the binding
of added radiolabeled, nonspecific oligonucleotide. Alterna-
tively, there may be conformational differences between the rat
brain protein isolated using only the magnetic particles and the
proteins isolated by reverse-phase HPLC that generate the
nonspecific site. But the physiological significance and detailed
analysis of this nonspecific binding is beyond the scope of this
communication.
Although some hnRNPs have high affinity for oligonucleo-
tides regardless of sequence, they may also have additional,
more specific functions (23, 42). hnRNP A2 binds the telomeric
sequence TTAGGG (24, 25, 43), which bears no relationship to
the A2RE sequence and is therefore unlikely to mimic the
A2RE binding detected in this study. Because heparin was not
used in the studies with telomeric DNA, it is possible that the
TTAGGG sequence binds with an atypically high affinity to the
nonspecific site; alternatively, it may interact with a specific
site on hnRNP A2 other than the one described here.
The size of the A2RE-binding site on hnRNP A2 was earlier
suggested to be around 11 nucleotides, based on an analysis of
the effects of mutations within the A2RE11 (29). This conclu-
sion is reinforced by the data presented here: several single
base mutations within A2RE11 increased the dissociation con-
stant by more than 50-fold. Examination of the A2RE sequence
reveals an interesting near-repetition of the A2RE11 sequence
that results in significant binding of the 39 11 nucleotides and
the middle 11 nucleotides of A2RE to hnRNP A2 (29). A loose
analogy may be drawn with the parallel and antiparallel tan-
dem repeats found in the DNA segments recognized by tran-
scription factors, but the repeats in A2RE are single-stranded,
imperfect, and overlapped. Furthermore, although the A2RE
has, as a result of this repetition, potentially more than one
binding site, only one molecule of hnRNP A2 is bound.
Unless the interaction with hnRNP A2 has a pronounced
effect on its secondary structure, the protein-bound A2RE is
likely to be single-stranded. Calculations using the program
mfold (44) indicate that neither A2RE nor A2RE11 and its
mutants forms stable secondary structure, with the exception
of A8G, which can form 3 base pairs. Therefore, although these
calculations are more reliable for larger oligonucleotides, per-
haps the closest parallels can be drawn between A2RE-hnRNP
A2 and the RNA complexes formed by Sex-lethal protein and
the N-terminal tandem RRMs of poly(A) binding (PABP) pro-
tein. Nine nucleotides of a 12-nucleotide segment of single-
stranded transformer mRNA bind in a V-shaped cleft formed by
the tandem RRMs of Sex-lethal protein (45, 46). Seven consec-
utive nucleotides of poly(A) are bound in a narrow trough
formed by the b-strands of the RRMs of PABP (46, 47). The
stretches of RNA bound to these proteins, 7–9 nucleotides, are
comparable in length with A2RE11. In both of these complexes,
FIG. 9. Specific binding site of
hnRNP A2 requires both RRMs. Meas-
urements of the binding of hnRNP A2 and
fragments to biosensor surfaces bearing
dA2RE or dNS1. Both RRM1 (326 nM) and
RRM2 (293 nM) manifest equivalent bind-
ing to A2RE and NS1 (A and B), indicat-
ing that they bind A2RE very weakly, if at
all, compared with the intact protein (30
nM in C). The data for the individual
RRMs were recorded at a single concen-
tration corresponding to the maximum
used with intact hnRNP A2 in earlier ex-
periments. Because no specific binding
was evident, experiments were not per-
formed at other protein concentrations.
The concatenated repeats (RRM1 1
RRM2) showed some specific binding (D),
but the RRMs with the 10 additional
flanking residues (i.e. 1–189; E) ap-
proached the binding of intact hnRNP A2
(F). The curves in D--F represent the best
fit to the data assuming one (NS1) or two
(A2RE) sites (see Table III).
TABLE II
Effect of A2RE point mutations on hnRNP A2 binding
Oligoribonucleotides having point mutations were added to a biosensor cuvette bearing immobilized hnRNP A2. The biosensor responses (Fig.
8B) were fitted to a two-site model, yielding dissociation constants (nM) for specific and nonspecific sites.
C3G G7A A8G G9A A2RE11
Specific 62 6 10 92 6 18 .5000 .5000 44 6 7
Nonspecific 248 6 44 262 6 41 233 6 44 250 6 42 244 6 31
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however, some of the 29-OH groups interact with the proteins,
whereas the similar affinity displayed for A2RE and its 29-
deoxy counterpart by hnRNP A2 suggests that the 29-OH
groups of A2RE do not play such a role.
The small number of structural studies of RNA binding to
RRM-containing proteins has uncovered considerable diversity
in the modes of interaction, including the binding of single (48)
or multiple RRMs (45), binding of single- and double-stranded
RNA, and monomeric or self-associated proteins. UP1, the two
tandem RRMs of hnRNP A1, for example, binds nucleic acid
homopolymers through only one of its RRMs (48). UP1 can also
form antiparallel dimers in which two single-stranded DNA
segments straddle both protein molecules, binding RRM1 of
one molecule and RRM2 of the other (49). The RRMs lie side-
by-side in the crystal structure of UP1 (13). It is possible that
UP1 is not dimeric in solution and has an altered mode of
oligonucleotide binding (49).
A2RE appears to bind to monomers of hnRNP A2; equivalent
results were obtained in the experiments reported here with
the A2RE or hnRNP A2 immobilized on the biosensor surface.
As the protein in these experiments was immobilized from a
solution in which it was shown by sedimentation equilibrium
experiments to be monomeric, it is unlikely that the observed
A2RE binding is to a dimer of the protein. In addition, hnRNP
A2 (or A1) added to a biosensor bearing immobilized hnRNP A2
resulted in no increase in response, again indicating that, un-
der the conditions used, hnRNP A2 does not self-associate or
bind hnRNP A1.
Although the glycine-rich region of hnRNP A1 has been
implicated in other RNA-hnRNP interactions (11, 39), this
region of hnRNP A2 does not appear to be involved in the
interaction with A2RE. The expressed segment of hnRNP A2,
including both RRMs and the short region C-terminal to the
second RRM that has been shown previously to markedly en-
hance RNA binding to hnRNP A1 (38), bound A2RE almost as
strongly as the full protein. Binding to the individual RRMs
was weak or undetectable. Thus, the specific association ap-
pears to involve a 1:1 interaction of monomeric hnRNP A2 with
a short single-stranded RNA, the binding site being formed by
the two RRMs. Verification of this model will await more de-
tailed structural studies, such as three-dimensional structure
determination of the RNA-protein complex.
In summary, we have demonstrated that: (i) recombinant
hnRNPs A1 and A2 possess a site capable of binding RNAs with
diverse sequences; (ii) in addition, both possess a site that
binds the 21-nucleotide A2RE but not equivalent oligonucleo-
tides with scrambled sequences; (iii) A2RE binding to the spe-
cific site on hnRNP A2 is considerably stronger than to hnRNP
A1; (iv) the 59 11 nucleotides of A2RE bind to hnRNP A2 with
an affinity equal to that of the 21-mer, thus the sequence-
specific binding involves at most 11 nucleotides; (v) several
single base mutations within the A2RE abrogate specific bind-
ing to hnRNP A2; and (vi) the specific binding site is formed by
the two tandem RRMs and the proximal C-terminal flanking
region. It is hoped that the present demonstration of the exist-
ence on hnRNP A2 of a site exhibiting specificity for A2RE may
prompt further investigations to identify more closely the oli-
goribonucleotide-binding sites on the heterogeneous nuclear
ribonucleoproteins involved in mRNA transport.
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